<scp>BAX</scp> and <scp>BCL</scp>‐2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the <scp>R</scp>etina 4 project

Abstract

Results suggest that A allele of rs4645878 could be a biomarker of high risk of developing PVR in patients undergoing RD surgery. The possible role of BCL-2 (inhibitor of necroptosis pathway) as a possible new target in PVR prophylaxis should be investigated.